Echt, Netherlands

Erwin Suir

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Erwin Suir: Innovator in Microorganism Technology

Introduction

Erwin Suir is a notable inventor based in Echt, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the area of microorganism development for diterpene production. With a total of 2 patents to his name, Suir's work is paving the way for advancements in sustainable production methods.

Latest Patents

Suir's latest patents focus on recombinant microorganisms that enhance the production of diterpenes. One of his key inventions involves a microorganism that comprises nucleotide sequences encoding various polypeptides, including ent-copalyl pyrophosphate synthase, ent-Kaurene synthase, ent-Kaurene oxidase, and kaurenoic acid 13-hydroxylase. This innovative microorganism is designed to produce steviol, a compound with various applications. Additionally, the microorganism may express UDP-glucosyltransferases, enabling it to produce steviol glycosides, further expanding its utility in biotechnological applications.

Career Highlights

Erwin Suir is currently associated with Dsm IP Assets B.V., where he continues to develop innovative solutions in the field of biotechnology. His work is characterized by a commitment to enhancing the efficiency and sustainability of microbial production processes.

Collaborations

Suir collaborates with Viktor Marius Boer, a fellow innovator in the field. Their partnership exemplifies the collaborative spirit that drives innovation in biotechnology.

Conclusion

Erwin Suir's contributions to microorganism technology are significant and impactful. His patents reflect a dedication to advancing sustainable production methods in biotechnology. The innovations he is developing will likely play a crucial role in the future of this field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…